Goktas, M. T. Et Al. 2017. Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behcet's Disease. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.121, no.4 , 266-271.

Goktas, M. T., KARACA, R. O., KALKISIM, S., Cevik, L., KILIC, L., AKDOĞAN, A., ... BABAOĞLU, M. Ö.(2017). Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behcet's Disease. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.121, no.4, 266-271.

Goktas, MUSTAFA Et Al. "Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behcet's Disease," BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.121, no.4, 266-271, 2017

Goktas, MUSTAFA T. Et Al. "Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behcet's Disease." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.121, no.4, pp.266-271, 2017

Goktas, M. T. Et Al. (2017) . "Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behcet's Disease." BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , vol.121, no.4, pp.266-271.

@article{article, author={MUSTAFA TUĞRUL GÖKTAŞ Et Al. }, title={Decreased Activity and Genetic Polymorphisms of CYP2C19 in Behcet's Disease}, journal={BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY}, year=2017, pages={266-271} }